New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
09:27 EDTTMO, RHHBY, GE, LIFELife Technologies potential buyers could have better options, says Piper Jaffray
After Life Technologies (LIFE) said it hired two investment banks to aid in its annual strategic review, Piper Jaffray said it believes a takeover or leveraged buyout is potentially in the works. Piper said it sees several potential acquirers for Life, listing Roche (RHHBY), Thermo Fisher (TMO) and General Electric (GE) as possibly making strategic sense. However, Piper says the slower growing Research Consumables business makes up 43% of Life's revenue. As such, it believes an acquirer interested in the faster growing next-gen sequencing business has better options. Piper has a Neutral rating on shares of Life Technologies.
News For LIFE;RHHBY;TMO;GE From The Last 14 Days
Check below for free stories on LIFE;RHHBY;TMO;GE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 16, 2014
08:18 EDTGEGE announces presentation of new flutemetamol PET scan data
Subscribe for More Information
08:10 EDTGEBoeing, Airbus narrow engine choices in move toward efficient jets, WSJ says
Subscribe for More Information
06:26 EDTRHHBYBristol-Myers lung cancer trials being underestimated, says Citigroup
After building a statistical model of Bristol-Myers' two critical registration trials for Opdivo in lung cancer, Citigroup believes the market is "materially" underestimating both Phase III trials. Citi says potential Opdivo FDA approval in 2015 in lung cancer would give Bristol-Myers an up to two year lead time versus Merck (MRK) and Roche (RHHBY). The firm estimates 2023 Opdivo revenue at $7B and reiterates a Buy rating on Bristol with a $60 price target.
July 15, 2014
11:47 EDTGEGeneral Electric July volatility increases into Q2 and outlook
General Electric July call option implied volatility is 31, August is at 17, September is at 15; compared to its 26-week average of 17 according to Track Data, suggesting large near term price movement into the expected release of Q2 results before the open on July 18.
11:01 EDTGEGE wins orders from Lee Air for High Density Avionics Interface
Subscribe for More Information
10:47 EDTGEInterjet selects LEAP-1A to power A320neos in $2.9B order
Subscribe for More Information
09:46 EDTGEGE's FES selected by SpiceJet Airlines to support entire fleet
SpiceJet Airlines has selected GE’s (GE) Flight Efficiency Services to support its fleet of 52 Boeing (BA) 737 and Bombardier Q400 aircraft. GE will provide flight data analytics and fuel management to optimize the airline’s operational efficiency with the goal of substantially reducing fuel expenses for the airline. GE will provide consultation and evaluation services with the aim of reducing the airline’s fuel consumption and carbon emissions. GE is also designing and implementing custom solutions for SpiceJet and performing on-going efficiency measurements.
06:50 EDTGEGE anticipates meeting $30B air show goal, Reuters says
Subscribe for More Information
05:37 EDTRHHBYGenentech Avastin granted priority review by FDA
Subscribe for More Information
July 14, 2014
11:20 EDTRHHBYExelixis seen as potential target for Roche, TheStreet says
Subscribe for More Information
09:06 EDTGEEmirates signs $13B GE9X services agreement
Subscribe for More Information
07:43 EDTGEGE far ahead of Caterpillar in race for cleaner diesel train, WSJ says
Caterpillar (CAT) has fallen far behind in the race to offer a locomotive that meets stricter emission standards taking effect next year, with its Electro-Motive Diesel unit stating that its freight trains probably won't be available until 2017, while General Electric (GE) is already testing trains that comply with the new rules, reported The Wall Street Journal. Reference Link
July 13, 2014
11:40 EDTGEAmerican selects CFM engine to power A320 in order valued $2.6B
American Airlines (AAL) has selected CFM International’s advanced LEAP-1A engine to power its new fleet of 100 Airbus (EADSY) A320neo family aircraft. CFM values the engine order at $2.6B U.S. at list price. The aircraft order was originally announced in July 2011 and American will begin taking delivery in 2017. American also has orders for LEAP-1B engines to power 100 Boeing 737 MAX aircraft, which are also scheduled to be delivered beginning in 2017. American has been a CFM customer since 1996 and the airline’s fleet includes 375 Airbus A320 Family and Boeing 737 aircraft powered by CFM56 engines. CFM International is a 50/50 joint company between Safran and General Electric (GE).
July 12, 2014
18:08 EDTGEeasyJet said to choose GE-Safran engine for Airbus jets, WSJ says
easyJet (ESYJY) is set to order engines from a partnership of General Electric (GE) and France's Safran to power 100 Airbus Group (EADSY) NV A320neo jets, says the Wall Street Journal. According to the WSJ report United Technologies (UTX) unit Pratt & Whitney was also aggressively competing for the order. Reference Link
July 11, 2014
08:05 EDTGEGE Capital increases credit facility for OraMetrix
GE Capital’s Healthcare Financial Services business announced that it is the sole lender on a $10M senior secured term loan for OraMetrix. This transaction refinances the company’s previous $7.5M multi-draw senior secured term loan facility and provides it with an additional $2.5M. The funds will be used for working capital and growth initiatives.
08:03 EDTGEGE Capital provides MerchSource with $130M credit facility
GE Capital announced it is providing MerchSource with a $130M senior credit facility providing working capital for the company’s operations in the U.S. and Hong Kong.
07:45 EDTGEWith Alstom agreement settled, attention on GE turns to earnings, Reuters says
Subscribe for More Information
July 10, 2014
10:02 EDTRHHBYRoche unit, Merck KGaA to develop companion test for cancer treatment
Ventana Medical Systems, a member of the Roche Group (RHHBY), announced it has entered into an agreement with Merck KGaA (MKGAY), which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic for an undisclosed target using Ventana's proprietary diagnostic assays.
07:29 EDTGEGeneral Electric volatility elevated into Q2 and revenue outlook
Subscribe for More Information
July 9, 2014
07:06 EDTGEUniversal Stainless & Alloy achieves S-400, S-1000 approvals from GE Aviation
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use